胰岛素瘤腹腔镜外科治疗体会

目的 评估腹腔镜胰岛素瘤切除术的可行性和安全性。方法 2002年6月至2004年6月25例胰岛素瘤患者,分别行腹腔镜胰岛素瘤切除术（腹腔镜组,10例）和开腹胰岛素瘤切除术（开腹手术组,15例）,比较2组手术时间、术中出血量、术后住院天数和并发症发生率差异是否有统计学意义。结果 肿瘤发生部位、大小差异无统计学意义,手术时间、术中出血量和术后平均住院天数等差异均无统计学意义（P〉0．05）。并发症发生率方面,腹腔镜手术组仅1例并发胰瘘,开腹手术组3例并发胰瘘、2例并发腹腔感染、5例并发胸腔积液,开腹手术组并发症发生率显著高于腹腔镜手术组（P〈0．01）。结论 位于胰体或尾部的胰岛素瘤行腹腔镜下胰岛素瘤切除术是安全可行的,并且并发症发生率低于经典的开腹手术。     

近端胰岛素瘤的腹腔镜切除

目的:探讨近端胰岛素瘤切除术的技术要点、可行性及安全性。方法:回顾分析2003年3月至2010年2月行腹腔镜手术治疗38例胰岛素瘤患者的临床资料,按肿瘤位置分为近端组和远端组,探讨两组的技术要点,分析两组的手术方式、手术时间、出血量及并发症发生率。结果:2例未找到病灶终止手术,36例顺利完成手术,其中近端组16例,远端组21例(1例为颈、体多发肿瘤同时计入两组)。近端组均行肿瘤切除术,远端组包括肿瘤切除术6例,胰体尾切除术15例(其中保脾7例)。近端组与远端组相比,手术中转率(18.8%vs.14.3%)、并发症发生率(56.3%vs.28.6%)、手术时间[(205±66.7)minvs.(202±90.0)min]差异无统计学意义(P0.05),出血量较少[(68.7±49.4)ml vs.(118.0±98.3)ml,P0.05)],术后住院时间明显延长[(14.4±8.2)d vs.(7.6±1.7)d,P0.05)]。结论:近端胰岛细胞瘤的腹腔镜切除总体是安全可行的,但与远端胰腺胰岛素瘤相比技术难度较大,需要谨慎选择合适的病例。     

腹腔镜胰岛素瘤切除术

<正>患者,女。晨起不能唤醒2月余,有时口吐白沫、大小便失禁、大汗淋漓,进食后缓解。其家人疑为精神病,将其送往精神病医院,治疗无效来我院,查血糖0.52mmol/L。确诊为胰岛素瘤,需手术治疗。 取仰卧位,常规建气腹、置入腹腔镜。超声刀分离切断胃结肠韧带,打开小网膜囊显露胰腺,游离胰体尾下缘并向上翻起,见胰腺背面、胰体尾交界处有直径1.5cm结节,淡黄色、质韧、界清,与脾静脉关系密切。超声刀沿脾静脉、瘤体边缘将之完整切     

腹腔镜多发胰岛素瘤切除术1例报告

目的:探讨腹腔镜切除多发胰岛素瘤的可行性.方法:2010年7月2日为1例多发胰岛素瘤患者(胰体尾部各一)施行腹腔镜切除术.结果:手术顺利,手术时间52min,出血约15ml,术中放置引流管,术后各项指标恢复正常,症状完全缓解,术后第2天进食,1周出院,2周拔除引流管,无其他并发症发生.结论:位于表浅部位的胰岛素瘤或其他...     

腹腔镜下胰岛素瘤切除13例

【摘要】 目的 探讨完全腹腔镜下胰岛素瘤手术切除的可行性、安全性。方法 我科2008年1月~2012年9月住院的对13例胰岛素瘤患者行完全腹腔镜下肿瘤切除的临床资料进行回顾性分析,并总结其主要技术环节。结果 13例患者在腹腔镜超声指导下成功实施镜下胰岛素瘤切除术,其中行单纯肿瘤切除术7例,胰体尾+脾切除4例,保留脾脏胰体尾切除术2例,过程顺利,血糖监测提示手术效果满意,术后胰漏3例,保守治疗痊愈,术后无严重腹腔感染和大出血发生。随访无复发。结论 腹腔镜下行胰岛素瘤切除安全、微创、可行,尤其是结合腹腔镜术中超声可有助于胰岛素瘤的的准确定位及选择合适的手术方式。     

腹腔镜治疗功能性胰岛素瘤的临床应用疗效：附11例报告

背景与目的:胰岛素瘤是最常见的功能性胰岛细胞肿瘤,手术是唯一能治愈的方法。随着技术与设备的发展,腹腔镜下手术已被医患所认可。本研究旨在探讨腹腔镜胰岛素瘤切除术的可行性及疗效。方法:回顾性分析2016年7月—2019年5月笔者所在单位行腹腔镜胰岛素瘤切除术的11例患者的围手术期临床资料及随访资料。结果:11例患者中,男4例,女7例;就诊时年龄21～62岁,平均44.8岁;病程8 d至4年,术前定性、定位诊断均为胰岛素瘤。10例在腹腔镜下成功切除肿瘤,其中行胰岛素瘤切除术8例(胰腺颈部2枚,体部5枚,尾部2枚);2例行胰体尾切除术(胰腺体部1枚,尾部1枚)。11例均行术中腹腔镜超声检查,10例患者发现肿瘤,共11枚,1例腹腔镜超声未探及肿瘤,终止手术。手术时间85.0～380.0 min,术中出血量10.0～530.0 mL。肿瘤切除30 min后,血糖升高1.5～2.3 mmol/L;术后第1天清晨血糖3.9～10.4 mmol/L,出院时血糖2.4～12.8 mmol/L。术后病理均为良性胰岛素瘤。3例术后出现并发症,1例出现胰瘘(A级),2例出现反跳性高血糖。术后住院时间5.0～15.0 d。随访10～43个月,完整切除肿瘤的10例患者,低血糖症状完全消失,无肿瘤复发。结论:胰颈、体尾部表面及适合胰体尾切除的良性胰岛素瘤,腹腔镜下手术切除安全、有效、创伤小,临床可推广应用。     

腹腔镜治疗胰腺体尾部的良性胰岛素瘤：单中心经验

广泛发展的微创外科允许外科医师通过此途径进行复杂的手术操作，如胰腺切除，尽管其实际价值仍有争议。该中心从2000年1月到2005年9月对5男7女连续12例胰岛素瘤病人进行腹腔镜外科手术。所有病人都有典型的症状，实验室检查提示：高胰岛素血症。病人情况适宜行腹腔镜外科手术。评估内容包括：术前诊断、手术时间、术后并发症的发生率、平均住院日、以及临床预后。12例中有11例成功实施腹腔镜手术。     

胰岛素瘤22例诊治分析

【摘要】 目的 探讨胰岛素瘤的诊断和治疗方法。方法 回顾性分析南通市瑞慈医院和南通市第一人民医院近15年来治疗的22例胰岛素瘤的临床资料。结果 全组22例均有Whipple三联征。术前B超、CT、MRI、门静脉穿刺分段取血胰岛素测定诊断的阳性率分别为15.8%（3/19）、67.5%（10/16）、71.4%（5/7）、100%（2/2）,术中B超的诊断阳性率85.7%（6/7）。行肿瘤局部切除13例,胰体尾切除3例,胰体尾切除+脾脏切除1例,胰十二指肠切除1例,保留十二指肠的胰头切除1例,腹腔镜下胰岛素瘤切除3例。22例均为良性肿瘤。术后低血糖症状均消失。结论 Whipple三联征结合IRI/G比例的测定是定性诊断的主要依据。多层螺旋CT双期胰腺薄层扫描是定位诊断的主要手段,术中B超是对术前定位诊断的检验和补充。肿瘤切除是胰岛素瘤的主要术式,腹腔镜胰岛素瘤切除应得到推崇。     

单中心51例单孔腹腔镜肝切除经验总结

目的:探讨单孔腹腔镜肝切除术的疗效及安全性,总结其手术经验。方法:回顾分析2009年12月至2015年8月完成的51例单孔腹腔镜肝切除术的临床资料,并对比良恶性疾病接受单孔腹腔镜肝切除术的疗效。全组共51例患者(男18例,女33例),良性疾病38例,恶性疾病13例,平均(43.51±11.83)岁。结果:51例单孔腹腔镜肝切除术均成功完成,无加孔或中转开腹。手术时间平均(112.65±53.23)min,其中良性疾病平均(97.11±25.33)min,恶性肿瘤平均(158.08±82.63)min;术中失血量平均(165.88±135.29)ml,其中良性疾病平均(141.05±96.92)ml,恶性肿瘤平均(238.46±199.12)ml;术后排气时间平均(1.76±0.62)d,其中良性疾病平均(1.66±0.58)d,恶性肿瘤平均(2.69±0.86)d;术后平均住院(5.18±2.21)d,其中良性疾病平均(4.42±1.48)d,恶性肿瘤平均(7.38±2.53)d。除2例患者术后发生出血外,无胆漏、胸腔积液等并发症发生。结论:传统腹腔镜器械完成单孔腹腔镜肝左叶病变切除具有良好的疗效及美容效果。病灶局限肝左外叶的良性病例是单孔腹腔镜肝切除术的良好适应证。     

腹腔镜胰十二指肠切除术单中心73例经验总结

背景与目的:胰十二指肠切除术(PD)操作复杂,是普通外科领域难度较大的手术之一。随着微创外科技术的发展,腹腔镜PD(LPD)已逐渐普及,并日趋成熟。本研究对笔者所在单位LPD的经验进行总结,以期进一步提高该手术的疗效与成功率。方法:回顾性分析2016年1月-2018年12月期间由中国科学技术大学附属第一医院胆胰外科同一团队开展的73例行LPD患者的围手术期临床资料及随访资料。结果:73例患者中,男31例,女42例;平均年龄(55.66±11.70)岁。平均手术时间(601.3±100.0)min,平均术中出血量(448.6±313.3)mL。术后胰瘘27例(36.9%),其中生化漏16例(21.9%),B级胰瘘6例(8.2%),C级胰瘘5例(6.8%);胃排空延迟发生46例(63.0%);术后出血6例(8.2%)。术后再手术者4例(5.4%),均为术后出血患者,围手术期死亡1例(1.4%)。术后病理学诊断为恶性肿瘤63例(86.3%),其中十二指肠乳头癌31例,胆总管下段癌13例,壶腹部恶性肿瘤14例,胰头癌5例;良性占位10例(13.7%),其中胰腺实性加乳头状瘤6例,胰头部黏液性囊腺瘤3例,胰腺神经内分泌瘤1例。随访时间4~35个月,平均11.5个月,期间未出现死亡病例。结论:LPD安全、可行,术后的并发症发生率在可接受的范围内,并可以达到根治性的手术要求。随着手术经验的不断积累,腹腔镜设备和器械不断改进,可广泛推广应用。     

Laparoscopic treatment of pancreatic insulinoma

Laparoscopy and laparoscopic ultrasonography (LUS) have been proposed for the diagnosis and treatment of pancreatic insulinoma. We present for cases of pancreatic insulinoma approached by laparoscopy guided by LUS. In three cases, insulinomas were in the pancreatic body and in one case in the pancreatic head. All lesions were detected preoperatively by abdominal US and confirmed by computed tomography. Laparoscopy was performed under general anesthesia. LUS was performed using a 10-mm flexible probe. In two cases the adenoma was enucleated using scissors and electrocoagulation, major vessels were controlled using clips, and enucleation was completed using a 30-mm endo-GIA. In one case a laparoscopic distal pancreatectomy with spleen preservation was performed. In one case the adenoma was deep in the pancreatic head; minilaparotomy was performed and the adenoma enucleated. Patients were discharged in good health 5–7 days after surgery. The postoperative course was complicated in one case of enucleation by peripancreatic fluid collection that was treated percutaneously. Our experience confirms that accurate localization followed by excision of tumors via the laparoscopic approach constitute a significant advance in the management of insulinoma.     

Laparoscopic approach for solitary insulinoma: a multicentre study

Background Surgical resection of insulinomas is the preferred treatment in order to avoid symptoms of hypoglycaemia. During the past years, advances in laparoscopic techniques have allowed surgeons to approach the pancreas and treat these lesions laparoscopically. We analysed the feasibility, safety, and outcome of patients undergoing laparoscopic resection of insulinomas in a large, retrospective, multicentre study.Methods Thirty-six patients with pancreatic insulinomas were enrolled in this study. All patients were suspected of having solitary insulinomas after preoperative localisation tests and underwent a laparoscopic approach. Patients, operating characteristics and outcome were analysed.Results Mean patient age was 48 years (range 20–77 years). Insulinomas were localised in the head (n=7), isthmus (n=2), body (n=14) or tail (n=13) of the pancreas before laparoscopic approach. Mean size of the lesions was 15.5 mm (range 4–25 mm). The surgical procedure was enucleation in 19 cases (52%), spleen-preserving distal pancreatectomy in 12 cases (33%), spleno-pancreatectomy in three cases (8%), one duodenopancreatectomy and one central pancreatectomy. Conversion rate was 30%. The reason for conversion in seven patients (63%) was the inability to localise the tumour during the laparoscopic procedure. In six of these cases laparoscopic ultrasonography was not performed. Mean operating time was 156 min (range 50–420 min). Postoperative course was uneventful in 23 patients (64%). Eleven patients (30%) developed specific complications of pancreatic surgery: intra-abdominal abscess (n=6) or pancreatico-cutaneous fistula (n=5). Mean duration of fistulae was 55 days (range 5–130 days) and all the fistulae were dry at follow-up. After a mean follow-up period of 26 months (range 2–87 months), 33 patients (91%) are free of symptoms, and three patients have been lost to follow-up.Conclusion The laparoscopic approach is safe to treat preoperatively localised insulinoma, with a morbidity rate comparable to that for the open approach. When the tumour is not found during laparoscopy, laparoscopic ultrasonography seems to be the most efficient tool to localise it and probably to prevent conversion.     

Laparoscopic pancreatic surgery: Current indications and surgical results

Background: Although minimally invasive surgery has achieved worldwide acceptance in various fields, laparoscopic surgery for pancreatic diseases has been reported only rarely. The purpose of this study was to evaluate the outcomes and feasibility of laparoscopic pancreatic surgery. Methods: Fifteen patients, comprising eight men and seven women with an average age of 54 years, underwent laparoscopic pancreatic surgery. Distal pancreatectomy was indicated for solid tumors (n = 4), cystic lesions (n = 3), and chronic pancreatitis (n = 2). Cystogastrostomy was performed for pseudocysts (n = 4) and enucleation for insulinomas (n = 2). The lesions varied in size from 1 to 9 cm (2.9 ± 2.4 cm) and were located in the pancreatic head (n = 2), body (n = 3), or tail (n = 10). For distal pancreatectomy, the splenic artery was divided and the parenchyma was transected with a linear stapler. Laparoscopic ultrasonography was used to determine the distance between the tumor and the main pancreatic duct for enucleation as well as to localize the lesion for distal pancreatectomy. Cystogastrostomy, 4.5 cm in length, was also performed with the linear stapler through the window of the lesser omentum. Results: Mean operation time was 249 ± 70 min (293 ± 58 min in distal pancreatectomy, 185 ± 14 min in enucleation, 204 ± 50 min in cystogastrostomy), and mean blood loss was 138 ± 184 g (213 ± 227 g, 75 ± 35 g, 38 ± 48 g, respectively). Two distal pancreatectomies (13%) were converted to open surgery due to severe peripancreatic inflammation. There was no related mortality, but there were two cases (15%) of pancreatic fistula, one in a distal pancreatectomy case and the other in an enucleation case, and both were treated conservatively. Conclusions: Laparoscopic pancreatic surgery is safe and feasible for patients with benign tumors and cystic lesions.     

腹腔镜胰腺远端切除术26例

目的探讨腹腔镜胰腺远端切除术的安全性、可行性。方法2005年9月～2008年6月,对26例胰腺体尾部肿物行腹腔镜胰腺远端切除术。术前25例诊断为胰腺体尾部良性肿物,1例不除外恶性,肿物中位直径5cm（1.2～10cm）。结果所有手术均在全腹腔镜下完成。15例行保留脾脏的胰体尾切除（10例保留脾动静脉,5例未保留脾动静脉）,10例行胰体尾加脾切除,1例既往行胰体尾及脾切除者行胰体部切除。手术中位时间268.5min（129～400min）,中位出血量100ml（50～800ml）,术后中位住院时间9d（6～21d）。无胰漏或脾梗死发生,2例包裹性积液,均保守治疗治愈,1例引流管口感染。26例中位随访时间15.5月（1～35个月）,均无复发。结论胰腺体尾部良性肿物行腹腔镜胰腺远端切除术安全、可行。     

Distal pancreas surgery: outcome for 19 cases managed with a laparoscopic approach

Background In the past decade, laparoscopy has shown its efficacy also for advanced surgery. In this report, the authors retrospectively review their experience with the distal pancreas. Methods From April 1999 to October 2004, 19 patients underwent a laparoscopic procedure for pathologies of the distal pancreas. The authors performed one distal pancreatectomy (DP) with conservation of the spleen and section of the splenic vessels, four distal splenopancreatectomies (DSP), one DSP plus a left adrenalectomy, two enucleations, seven DPs with conservation of the spleen and the splenic vessels, and four cystojejunostomies. Results One procedure was converted to open surgery because of a hemorrhagic complication. No other significant intraoperative complications occurred. The postoperative course was characterized by one bleed managed conservatively, two pancreatic fistulas (one requiring a second operation), one abscess drained under echographic view, and one reactive pancreatitis. The mean postoperative stay was 8.5 days. The histologic report showed 16 benign diseases and 3 malignant tumors. The mean follow-up period was of 42 months. The patient who had DP spleen preservation with section of the splenic vessels reported mild pain in the left hypochondrium, probably attributable to chronic splenic ischemia, during the first 3 postoperative months. One incisional hernia occurred in the patient who underwent conversion to an open procedure, and one patient affected by adenocarcinoma died 10 months after the operation. Conclusions The authors can affirm that laparoscopy for the distal pancreas is a successful procedure in terms of results and surgical feasibility. Prospective studies are necessary to confirm their positive impression.     

机器人保留脾血管胰体尾切除术治疗儿童胰岛素瘤报道

目的报道国内外首例儿童机器人保留脾血管胰体尾切除术,探讨该方法治疗儿童胰腺良性疾病的可行性和安全性。 方法2016年7月收治1例儿童胰体尾胰岛素瘤病例,患儿女性,9岁,体质量24 kg,身高1.20 m。行机器人保留脾血管的胰体尾切除术。机器人操作时采用4孔法：自脐下缘微小切口置入气腹针建立气腹后缝合该切口,观察孔位于下腹正中脐下5 cm(10 mm),1臂位于左侧平脐水平与腋前线的交点(8 mm),2臂位于右侧脐水平下2 cm与腋前线交点(8 mm),辅助孔位于左侧锁骨中线脐水平下3 cm(12 mm)。用超声刀切开胃结肠韧带,显露胰腺,腹腔镜超声探查证实病灶位于胰尾,直径约2 cm;切断脾结肠韧带,结肠脾曲向下游离;用电凝沿胰腺下缘分离胰后间隙,向脾门进行,将胰尾与脾脏之间的粘连分开,于胰腺后方分离出脾静脉,胰腺上缘分离出脾动脉,逐一分离夹闭或缝合动静脉与胰腺之间的分支,使胰尾完全游离,距离肿瘤右侧约1 cm以直线切割闭合器蓝色钉仓切断胰体尾,胰腺断端以4-0 Prolene线连续缝合。标本装入一次性标本袋自辅助孔取出,胰腺断端放置乳胶引流管1根自腹壁右侧孔引出。 结果手术时间155 min,气腹时间120 min,术中出血量约10 ml,围手术期恢复顺利,无胰瘘、出血及腹腔感染等并发症。术后血糖恢复正常,空腹胰岛素及血糖比值小于0.4,胰腺MRI平扫及增强扫描显示胰腺无肿瘤残留。 结论机器人与传统腹腔镜相比,具有三维视野、操作灵活等优点,该病例的成功经验初步显示机器人保留脾血管的胰体尾切除术治疗儿童胰岛素瘤是安全、可行的。     

Laparoscopic enucleation of a pancreatic insulinoma

Insulinoma is the most common functional neuroendocrine tumor of the pancreas [2]. In most cases the lesions are benign, solitary, and located within the pancreatic parenchyma. Because of these characteristics, the majority of these lesions can be treated with simple enucleation [2]. Advances in laparoscopic techniques have recently enabled the safe resection of pancreatic islet cell tumors [1] and may provide patients with the benefits of minimally invasive surgery. This video demonstrates the technique of laparoscopic enucleation of a pancreatic insulinoma. The case presentation is that of a 40-year-old man who had symptoms of neuroglycopenia and was found to have elevated proinsulin levels during a 72-hour fast. Further evaluation included a CT scan, which revealed a 1.5 cm lesion on the posterior surface of the midbody of the pancreas. The video shows the operative technique of enucleation of the lesion, including positioning and trocar placement, performance of intraoperative ultrasound for tumor localization, and the use of specialized instruments (laparoscopic freer-elevator with a spatulated tip) that allowed enucleation of the lesion without excess handling of the tumor itself. The operation was performed in 105 minutes with minimal blood loss. The patient was fed clear liquid diet on the day after surgery and was discharged home on the third postoperative day. He had an uneventful recovery and has experienced no further symptoms. This multimedia article (video) has been published online and is available for viewing at http://www.springerlink.com. Its abstract is presented here. As a subscriber to Surgical Endoscopy you have access to our SpringerLink electronic service, including Online First.     

Kimura法保留脾脏的腹腔镜胰体尾切除术

目的探讨Kimura法保留脾脏的腹腔镜胰体尾切除术的安全性和可行性。方法回顾性分析2016年8月~2019年3月Kimura法保留脾脏的腹腔镜胰体尾切除术11例资料。均为胰体尾部单发病灶,直径2.0~5.0 cm,平均3.5 cm。结果11例手术均顺利完成,无中转开腹。手术时间125~185 min,平均155 min;出血量35~100 ml,平均65 ml,术中均未输注血制品;围手术期无死亡,无腹腔出血、B级或C级胰漏、脾梗死等严重并发症发生。术后住院6~12 d,平均7.8 d。11例随访1~32个月,中位数16个月,均未见肿瘤复发、转移及脾梗死。结论Kimura法保留脾脏的腹腔镜胰体尾切除术安全、可行。